Cometriq

Cometriq (Cabozantinib) is an oral medication used to manage certain types of cancer. This pharmaceutical is designed to target specific proteins involved in tumor growth and spread.

Cometriq is primarily used in the treatment of advanced thyroid cancer and renal cell carcinoma. It works by inhibiting the activity of proteins that promote cancer cell growth and metastasis. Patients often wonder, 'What is Cometriq used for?' This medication is typically prescribed for conditions where other treatments have proven ineffective.

Common effects of Cometriq may include fatigue, diarrhea, and decreased appetite. Some users also experience nausea, vomiting, and high blood pressure. These effects can vary in severity and may require monitoring by a healthcare professional.

Cometriq should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should also be aware of potential interactions with other medications and inform their doctor of any existing health conditions.

Cometriq may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid grapefruit and grapefruit juice, as they can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication while taking Cometriq.